Table 3.
Model 1: Multivariable linear regression analysis for financial toxicity (FACIT-COST score).
| Predictor | β (Estimate) | 95% CI | p-value |
|---|---|---|---|
| Age (years) | −0.02 | −0.17 to 0.13 | 0.774 |
| Comorbidities (Yes vs No) | 0.40 | −2.16 to 2.95 | 0.759 |
| Gleason risk group | |||
| Intermediate (low) | −1.68 | −7.08 to 3.72 | 0.540 |
| High (low) | −3.09 | −8.91 to 2.74 | 0.297 |
| Insurance type | |||
| Non-insured (private) | −3.98 | −8.38 to 0.42 | 0.076 |
| Public (private) | −0.50 | −3.56 to 2.56 | 0.747 |
| Treatment modality | |||
| Combined (local) | 0.95 | −2.23 to 4.14 | 0.554 |
| Systemic only (local) | 2.22 | −1.44 to 5.87 | 0.232 |
| Actual treatment coverage | |||
| None (full) | −5.75 | −9.69 to −1.80 | 0.005 |
| Partial (full) | −4.53 | −7.88 to −1.19 | 0.008 |
| Treatment disruption | |||
| Delay (none) | −7.33 | −10.58 to −4.07 | < 0.001 |
| Interruption (none) | −4.42 | −9.31 to 0.46 | 0.076 |
| Monthly household income | |||
| Low (high) | −13.73 | −17.39 to −10.07 | < 0.001 |
| Medium (high) | −6.70 | −9.90 to −3.49 | < 0.001 |
Outcome: FACIT-COST total score (continuous). Reference categories are in parentheses.